UnitedHealth Group (NYSE:UNH) Given “Overweight” Rating at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of UnitedHealth Group (NYSE:UNH) in a research note published on Tuesday morning,Benzinga reports. The firm currently has a $440.00 target price on the healthcare conglomerate’s stock.

Other equities analysts have also issued research reports about the company. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Barclays restated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $353.00.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $299.90 on Tuesday. The firm has a market cap of $271.61 billion, a P/E ratio of 12.99, a price-to-earnings-growth ratio of 1.97 and a beta of 0.43. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The business’s 50 day moving average is $288.15 and its 200-day moving average is $385.39.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.28% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds have recently modified their holdings of the company. MASTERINVEST Kapitalanlage GmbH bought a new position in UnitedHealth Group during the 2nd quarter worth $2,464,000. TT Capital Management LLC bought a new position in UnitedHealth Group during the 2nd quarter worth $489,000. Stance Capital LLC bought a new position in UnitedHealth Group during the 2nd quarter worth $1,297,000. Pathway Financial Advisers LLC raised its position in UnitedHealth Group by 6.8% during the 2nd quarter. Pathway Financial Advisers LLC now owns 7,221 shares of the healthcare conglomerate’s stock worth $2,253,000 after purchasing an additional 457 shares during the last quarter. Finally, North Dallas Bank & Trust Co. bought a new position in UnitedHealth Group during the 2nd quarter worth $1,329,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.